Leukemia is a cancer of the white blood cells and bone marrow. It is characterized by uncontrolled growth of blood cells. There are four major types of leukemia: acute or chronic myelogenous (AML, CML) and acute or chronic lymphocytic (ALL, CLL). The terms myelogenous and lymphocytic denote the type of cell involved.
Acute leukemia is a rapidly progressing disease that results in the accumulation of immature, functionless cells in the marrow and blood. The marrow often can no longer produce enough normal red and white blood cells and platelets.
Acute Myelogenous Leukemia (AML) is the most common type of leukemia in adults with approximately 10,100 new cases every year. AML accounts for just under half of cases of childhood leukemia.
This MediFocus Guide contains an extensive listing of citations and abstracts of recent journal articles that have been published about this condition in trustworthy medical journals. This is the same type of information that is available to physicians and other health care professionals. A partial selection of journal articles that are abstracted in this MediFocus Guide includes:
New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilities. Stem Cells. 2000
Acute myelogenous leukaemia and myelomonocytic blast crisis following polycythemia vera in HIV positive patients: report of cases and review of the literature. Annals of Oncology. 2000
Treatment of acute myelogenous leukemia in older adults. Leukemia. 2000
Treatment of relapsed and refractory acute myelogenous leukemia. Leukemia. 2000
Acute myelogenous leukemia and aging. Clinical interactions. Hematology - Oncology Clinics of North America. 2000
Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement. Cancer. 2000
Management of relapsed acute myeloid leukaemia. British Journal of Haematology. 1999
New developments in the treatment of acute myeloid leukemia. Advances in Experimental Medicine & Biology. 1999
Tailoring the treatment of acute myeloid leukemia. Current Opinion in Hematology. 1999
MediFocus.com understands that consumers who are facing serious medical issues need access to credible, up-to-date medical information to help them make informed health-care decisions. That's why we've developed the MediFocus Guides...the most advanced and trustworthy patient research guides for over 200 chronic and life-threatening conditions. Each MediFocus Guide includes a detailed overview of the condition including information about diagnosis, treatment options, cutting-edge research, and new developments; excerpts of important journal articles from the current medical literature focusing on standard treatments and treatment options; a directory of leading authors and medical institutions who specialize in the treatment of the condition; and a listing of organizations and support groups where you can obtain additional information about the illness.
MediFocus Guides are the perfect solution for consumers who wish to gain an in-depth understanding of their medical issue and avail themselves of the same type of professional level medical information that is used by physicians and other health-care professionals to help then in the clinical decision making process.
